PROGNOSTIC-SIGNIFICANCE OF PS2 PROTEIN EXPRESSION IN PULMONARY ADENOCARCINOMA

被引:23
作者
HIGASHIYAMA, M [1 ]
DOI, O [1 ]
KODAMA, K [1 ]
YOKOUCHI, H [1 ]
INAJI, H [1 ]
NAKAMORI, S [1 ]
TATEISHI, R [1 ]
机构
[1] CTR ADULT DIS, DEPT PATHOL, OSAKA 537, JAPAN
关键词
PULMONARY ADENOCARCINOMA; PS2; PROTEIN; IMMUNOHISTOCHEMISTRY; PROGNOSIS;
D O I
10.1016/0959-8049(94)90294-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the present study, pS2 protein expression in pulmonary adenocarcinoma was investigated on paraffin-embedded sections obtained from 170 patients. 28 (16%) patients showed varying degrees of pS2 protein expression in the cytoplasm of tumour cells, as detected by immunohistochemical staining with anti-pS2 protein antibody. There was a significant association between pS2 protein expression and larger tumour size, and the acinar or bronchiolo-alveolar subtype. However, no significant correlations between pS2 protein status and the other clinicopathological factors, i.e. T-factor, N-factor, stage and histological differentiation, were shown. In contrast to breast cancer, patients with pS2-positive pulmonary adenocarcinomas had a significantly worse prognosis than those with pS2-negative pulmonary adenocarcinomas; this was true for stage I patients, as well as for all patients. Multivariate analysis showed that pS2 protein expression was a discriminating variable in overall survival. These findings suggest that pS2 protein status is a possible prognostic indicator in pulmonary adenocarcinoma.
引用
收藏
页码:792 / 797
页数:6
相关论文
共 30 条
[1]   PROGNOSTIC RELEVANCE OF PS2-STATUS IN ASSOCIATION WITH STEROID-RECEPTOR STATUS AND PROLIFERATIVE ACTIVITY IN NODE-NEGATIVE BREAST-CANCER [J].
CAPPELLETTI, V ;
CORADINI, D ;
SCANZIANI, E ;
BENINI, E ;
SILVESTRINI, R ;
DIFRONZO, G .
EUROPEAN JOURNAL OF CANCER, 1992, 28A (8-9) :1315-1318
[2]   REGULATION OF CATHEPSIN-D AND PS2 GENE-EXPRESSION BY GROWTH-FACTORS IN MCF7 HUMAN-BREAST CANCER-CELLS [J].
CAVAILLES, V ;
GARCIA, M ;
ROCHEFORT, H .
MOLECULAR ENDOCRINOLOGY, 1989, 3 (03) :552-558
[3]  
COX DR, 1972, J R STAT SOC B, V34, P187
[4]   EXPRESSION OF THE PS2 PEPTIDE IN PRIMARY BREAST CARCINOMAS - COMPARISON OF MEMBRANE AND CYTOPLASMIC STAINING PATTERNS [J].
DOOKERAN, KA ;
RYE, PD ;
DEARING, SJ ;
WALKER, RA .
JOURNAL OF PATHOLOGY, 1993, 171 (02) :123-129
[5]  
FOEKENS JA, 1990, CANCER RES, V50, P3832
[6]   EXPRESSION OF THE PNR-2 PS2 PROTEIN IN DIVERSE HUMAN EPITHELIAL TUMORS [J].
HENRY, JA ;
BENNETT, MK ;
PIGGOTT, NH ;
LEVETT, DL ;
MAY, FEB ;
WESTLEY, BR .
BRITISH JOURNAL OF CANCER, 1991, 64 (04) :677-682
[7]   GROWTH STIMULATORY EFFECT OF PANCREATIC SPASMOLYTIC POLYPEPTIDE ON CULTURED COLON AND BREAST-TUMOR CELLS [J].
HOOSEIN, NM ;
THIM, L ;
JORGENSEN, KH ;
BRATTAIN, MG .
FEBS LETTERS, 1989, 247 (02) :303-306
[8]   USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) :577-580
[9]   SEQUENCE OF THE PS2 MESSENGER-RNA INDUCED BY ESTROGEN IN THE HUMAN-BREAST CANCER CELL-LINE MCF-7 [J].
JAKOWLEW, SB ;
BREATHNACH, R ;
JELTSCH, JM ;
MASIAKOWSKI, P ;
CHAMBON, P .
NUCLEIC ACIDS RESEARCH, 1984, 12 (06) :2861-2878
[10]   PANCREATIC SPASMOLYTIC POLYPEPTIDE (PSP) .3. PHARMACOLOGY OF A NEW PORCINE PANCREATIC-POLYPEPTIDE WITH SPASMOLYTIC AND GASTRIC-ACID SECRETION INHIBITORY EFFECTS [J].
JORGENSEN, KD ;
DIAMANT, B ;
JORGENSEN, KH ;
THIM, L .
REGULATORY PEPTIDES, 1982, 3 (3-4) :231-243